Document is current
Any future updates will be listed below
-
Authors
Thomas, Morgan
Matricon, Pierre G. https://orcid.org/0000-0001-9350-896X
Gillespie, Robert J.
Napiórkowska, Maja https://orcid.org/0009-0006-7171-5195
Neale, Hannah
Mason, Jonathan S.
Brown, Jason
Harwood, Kaan
Fieldhouse, Charlotte
Swain, Nigel A.
Geng, Tian https://orcid.org/0009-0005-3949-8242
O’Boyle, Noel M. https://orcid.org/0000-0003-4879-2003
Deflorian, Francesca
Bender, Andreas https://orcid.org/0000-0002-6683-7546
de Graaf, Chris
- License Information
-
More Information
Article History
Received: 22 October 2024
Accepted: 25 May 2025
First Online: 1 July 2025
Competing interests
: PGM, RJG, MN, HN, JSM, JB, KH, CF, NAS, TG, NOB, FD, and CdG are currently, or were, employees of Nxera Pharma UK while the work presented in this manuscript was conducted. Nxera Pharma UK is a drug discovery and development company working in the field of G-protein-coupled receptor structure-based drug design. All remaining authors declare no competing interests.
